v3.26.3
Share-based Compensations (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2026
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]    
Summarizes Share-based Compensation Expense by Function The following table summarizes share-based compensation expense by function for the three and six months ended June 30, 2026 and 2025:

Three Months Ended

Six months ended

June 30,

June 30,

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

Share-based compensation expense:

 

  ​

 

  ​

 

  ​

 

  ​

Selling, general and administrative

$

1,144,833

$

1,901

$

1,401,827

$

3,118

Research and development

 

33,267

 

16,354

 

58,153

 

25,370

Total share-based compensation expense

$

1,178,100

$

18,255

$

1,459,980

$

28,488

 
Summary of Stock Option Activity for Plan

The following table summarizes stock option activity for the Plan:

  ​

Weighted

Weighted

Average

 

 

Average

Remaining

 

Number of

 

Exercise

 

Contractual

  ​ ​ ​

Shares

  ​ ​ ​

Price

  ​ ​ ​

Term (years)

Outstanding at December 31, 2025

 

9,072,974

$

0.91

 

Granted

 

1,119,136

 

4.85

 

Exercised

 

(211,647)

 

 

Forfeited

 

(555,698)

 

 

Outstanding at June 30, 2026

 

9,424,765

$

1.45

 

8.12

Vested and Exercisable at June 30, 2026

 

4,210,766

$

0.20

 

7.37

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Weighted

Average

Weighted

Remaining

Average

Contractual

Number of

Exercise

Term

Shares

Price

(years)

Outstanding at January 1, 2024

 

5,643,900

$

0.00

 

  ​

Granted

 

752,520

$

0.00

 

  ​

Outstanding at December 31, 2024

 

6,396,420

$

0.00

 

  ​

Granted

 

2,686,075

$

3.09

 

  ​

Forfeited

 

(9,521)

$

0.67

 

  ​

Outstanding at December 31, 2025

 

9,072,974

$

0.91

 

9.05

Vested and Exercisable at December 31, 2025

 

3,831,951

$

0.16

 

7.87

Summary of Weighted Average Assumptions

The fair value of each option granted during the three and six months ended June 30, 2026 and 2025, was estimated on the date of grant using the weighted average assumptions in the table below:

Three Months Ended June 30,

  ​ ​ ​

Six Months Ended June 30,

 

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

 

Expected volatility

 

93.5

%  

49.7

%  

51.8

%  

49.3

%

Risk-free interest rate

 

4.3

%  

4.2

%  

3.9

%  

4.1

%

Expected term (in years)

 

6.0

 

6.1

 

6.0

 

6.1

Expected dividend yield

 

0.0

%  

0.0

%  

0.0

%  

0.0

%

The fair value of each option granted during the year ended December 31, 2025, was estimated on the date of grant using the weighted average assumptions in the table below:

Expected volatility

  ​ ​ ​

50.3

%

Risk-free interest rate

 

3.7

%

Expected term (in years)

 

5.9

Expected dividend yield

 

0.0

%

Summary of Restricted Stock

  ​ ​ ​

Weighted

Average

Grant

Date Fair

  ​ ​ ​

Number of Shares

  ​ ​ ​

Value

Unvested at December 31, 2025

499,720

$

0.00

Vested

 

(176,372)

 

Unvested at June 30, 2026

 

323,348

$

0.00

 
Summary of Restricted Stock Units

Weighted Average

Grant

  ​ ​ ​

Number of Shares

  ​ ​ ​

Date Fair Value

Unvested at December 31, 2025

$

0.00

Granted

2,683,680

5.00

Vested

 

(83,865)

 

5.00

Unvested at June 30, 2026

 

2,599,815

$

5.00

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Weighted Average
Grant Date Fair
Value

 

Unvested at January 1, 2024

1,410,975

$

0.00

Vested

(558,511)

$

0.00

Unvested at December 31, 2024

852,464

$

0.00

Vested

(352,744)

$

0.00

Unvested at December 31, 2025

499,720

$

0.00